EM
XPH icon

EnTrustPermal Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

EnTrustPermal Management’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-97,190
Closed -$3.74M – 35
2013
Q3 		$3.74M Sell
97,190
-24,186
-20% -$915K 3.48% 11
2013
Q2 		$4.28M Buy
+121,376
New +$4.1M 4.37% 7

Other funds holding XPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

EnTrustPermal Management's XPH Position: Q4 2013 in Review

EnTrustPermal Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2013, closing a stake of 97,190 shares — an estimated $3.74M sold.

EnTrustPermal Management first reported a position in XPH in Q2 2013 and held it in 2 quarters. The position peaked at $4.28M in Q2 2013. 65 funds tracked by Wall St. Rank hold XPH as of Q4 2013.

  • EnTrustPermal Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2013 after selling out during the quarter.
  • EnTrustPermal Management sold 97,190 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2013, an estimated $3.74M.
  • EnTrustPermal Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 2 quarters.
  • EnTrustPermal Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4.28M in Q2 2013.
  • 65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2013.

Based on EnTrustPermal Management's 13F filing for Q4 2013, filed 14 Feb 2014.